PAUSE: Sick Day Medication Management Mobile App Study

Launched by UNIVERSITY OF ALBERTA · May 22, 2024

Keywords

ClinConnect Summary

Our previous research surveyed healthcare providers from Alberta on "factors affecting clinician's decision to provide sick day medication guidance to patients with diabetes and CKD to prevent adverse events." Our results identified 75% of primary health providers were aware of sick day medication guidance, but just 56% knew where to find guidelines and resources. An overwhelming majority of respondents (97%) were supportive of enrolling patients in a study evaluating alternative innovations for providing sick day medication guidance.

In a recent scoping review summarizing existing interve...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • ≥18 years of age and able to provide informed consent
• • be able to communicate (read, write, and speak) in English
• • have access to a smartphone/tablet with an Internet connection
• • be willing and able to download and use the PC Health app for the duration of the study
• • currently be taking 2 or more medications from the following classes: renin-angiotensin-aldosterone system (RAAS) antagonists, diuretics, oral NSAIDs, metformin, or 1 or more medications from the following classes: insulin, sulfonylureas, meglitinides, SGLT2 inhibitors.
• Exclusion Criteria:
• • fail to meet the inclusion criteria
• • have kidney failure requiring maintenance dialysis
• • have had an organ transplant
• • are pregnant
• • receive qualifying medications in a blister pack or sachet
• • do not primarily manage their own medications and condition (i.e., receive home care, in a rehabilitation or medical respite facility)
• • cannot use the PC Health app independently
• • previously participated in studies that led to the development of the PAUSE App (including the PAUSE study usability testing or needs assessment focus groups)

Trial Officials